Interleukin-1β selectively decreases the synthesis of versican by arterial smooth muscle cells

Journal of Cellular Biochemistry

Volumn 101, Issue 3, 2007, Pages 753-766

  Lemire, Joan M ^a   Chan, Christina K ^b   Bressler, Steven ^b   Miller, John ^b,c   LeBaron, Richard G ^d   Wight, Thomas N ^b,e  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Decorin; Interleukin 1 ; Serglycin; Smooth muscle cells; Versican

Indexed keywords

BIGLYCAN; DECORIN; INTERLEUKIN 1BETA; MESSENGER RNA; VERSICAN; AMINO ACID; PROTEOGLYCAN; SCLEROPROTEIN; SULFATE; SULFUR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; GEL ELECTROPHORESIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA DEGRADATION; SEQUENCE ANALYSIS; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; ANIMAL; ARTERY; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME; VASCULAR SMOOTH MUSCLE;

AMINO ACIDS; ANIMALS; ARTERIES; BLOTTING, NORTHERN; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX PROTEINS; INTERLEUKIN-1BETA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEOGLYCANS; RNA, MESSENGER; SULFATES; SULFUR RADIOISOTOPES; TIME FACTORS; VERSICANS;

EID: 34247882682     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21235     Document Type: Article

References (72)

1. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
2. Amento EP, Ehsani N, Palmer H, Libby P. 1991. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11:1223-1230.
3. Benton HP, Tyler JA. 1988. Inhibition of cartilage proteoglycan synthesis by interleukin I. Biochem Biophys Res Commun 154:421-428.
4. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR. 1996. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 44:303-312.
5. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. 1998. Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis. Atherosclerosis 139:205-222.
6. Cattaruzza S, Schiappacassi M, Ljungberg-Rose A, Spessotto P, Perissinotto D, Morgelin M, Mucignat MT, Colombatti A, Perris R. 2002. Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem 277:47626-47635.
7. Chait A, Wight TN. 2000. Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol 11:457-463.
8. Chang Y, Yanagishita M, Hascall VC, Wight TN. 1983. Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J Biol Chem 258:5679-5688.
9. Chen JK, Hoshi H, McKeehan WL. 1991. Stimulation of human arterial smooth muscle cell chondroitin sulfate proteoglycan synthesis by transforming growth factor-β. In Vitro Cell Dev Biol 27:6-12.
10. Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. 2002. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 40:2072-2081.
11. Day AA, McQuillan CI, Termine JD, Young MR. 1987. Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone. Biochem J 248:801-805.
12. Demoor-Fossard M, Redini F, Boittin M, Pujol JP. 1998. Expression of decorin and biglycan by rabbit articular chondrocytes. Effects of cytokines and phenotypic modulation. Biochim Biophys Acta 1398:179-191.
13. Dours-Zimmermann MT, Zimmerman DR. 1994. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 269:32992-32998.
14. du Cros DL, LeBaron RG, Couchman JR. 1995. Association of versican with dermal matrices and its potential role in hair follicle development and cycling. J Invest Dermatol 105:426-431.
15. Edwards IJ, Wagner WD, Owens RT. 1990. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. Am J Pathol 136:609-621.
16. Edwards IJ, Xu H, Wright MJ, Wagner WD. 1994. Interleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler Thromb 14:1032-1039.
17. Evanko S, Raines EW, Ross R, Gold LI, Wight TN. 1998. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics and the proximity of PDGF and TGF-β1. Am J Pathol 152: 533-546.
18. Evanko SP, Angello JC, Wight TN. 1999. Formation of hyaluronan and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 1004-1013.
19. Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN. 2001. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys 394:29-38.
20. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC. 1996. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 315(Pt 1):335-342.
21. Fisher LW, Stubbs JT 3rd, Young MF. 1995. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl 266:61-65.
22. Fisher LW, Termine J.D, Young MF. 1989. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576.
23. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181-189.
24. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. 1996. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol 16:34-43.
25. Geary RL, Wong JM, Rossini A, Schwartz SM, Adams LD. 2002. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 22:2010-2016.
26. Gutierrez P, O'Brien KD, Ferguson M, Nikkari ST, Alpers CE, Wight TN. 1997. Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries. Cardiovasc Pathol 6:271-278.
27. Halpert I, Sires U, Potter-Perigo S, Wight TN, Shapiro DS, Welgus HG, Wickline SA, Parks WC. 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localized to areas of versican deposits. Proc Natl Acad Sci USA 93: 9748-9753.
28. Hsu JY, Hsu MY, Sorger T, Herlyn M, Levine EM. 1999. Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1. In Vitro Cell Dev Biol Anim 35:647-654.
29. Huang R, Merrilees MJ, Braun K, Beaumont B, Lemire J, Clowes AW, Hinek A, Wight TN. 2006. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 98:370-377.
30. Hughes CE, Caterson B, Fosang AJ, Roughley PJ, Mort JS. 1995. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: Application to catabolism in situ and in vitro. Biochem J 305 (Pt 3):799-804.
31. Iruela-Arispe ML, Hasselaar P, Sage H. 1991. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 64:174-186.
32. Järveläinen HT, Kinsella MG, Wight TN, Sandell LJ. 1991. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 266:23274-23281.
33. Keen RR, Nolan KD, Cipollone M, Scott E, Shively VP, Yao JS, Pearce WH. 1994. Interleukin-1 beta induces differ-ential gene expression in aortic smooth muscle cells. J Vasc Surg 20:774-784; discussion 784-786.
34. Kimata K, Oike Y, Tani K, Shinomura T, Yamagata M, Uritani M, Suzuki S. 1986. A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. J Biol Chem 261:13517-13525.
35. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R. 2002. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: Insights into plaque erosion. Arterioscler Thromb Vasc Biol 22: 1642-1648.
36. Kolset SO, Gallagher JT. 1990. Proteoglycans in haemopoietic cells. Biochim Biophys Acta 1032:191-211.
37. Kulseth MA, Kolset SO, Ranheim T. 1999. Stimulation of serglycin and CD44 mRNA expression in endothelial cells exposed to TNF-alpha and IL-1alpha. Biochim Biophys Acta 1428:225-232.
38. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
39. LeBaron RG, Zimmermann DR, Ruoslahti E. 1992. Hyaluronate binding properties of versican. J Biol Chem 267: 10003-10010.
40. Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN. 1999. Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:1630-1639.
41. Lemire JM, Merrilees MJ, Braun KR, Wight TN. 2002. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol 190:38-45.
42. Lin H, Ignatescu M, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, McManus BM. 1996a. Prominence of apolipoproteins B, (a), and E in the intimae of coronary arteries in transplanted human hearts: Geographic relationship to vessel wall proteoglycans. J Heart Lung Transplant 15:1223-1232.
43. Lin H, Wilson JE, Roberts CR, Horley KJ, Winters GL, Costanzo MR, McManus BM. 1996b. Biglycan, decorin and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: Distinctness as comared to native atherosclerosis. J Heart Lung Transplant 15:1233-1247.
44. Lin JM, Yamauchi M, Sato S. 1997. Effects of recombinant interleukin-1 beta on decorin gene expression in human periodontal ligament fibroblast and its possible transcriptional regulation. J Periodontal Res 32:225-232.
45. Matsuura R, Isaka N, Imanaka-Yoshida K, Yoshida T, Sakakura T, Nakano T. 1996. Deposition of PG-M/ versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty. J Pathol 180:311-316.
46. Mauviel A, Korang K, Santra M, Tewari D, Uitto J, Iozzo RV. 1996. Identification of a bimodal regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene. J Biol Chem 271:24824-24829.
47. Mazzucato M, Cozzi MR, Pradella P, Perissinotto D, Malmstrom A, Morgelin M, Spessotto P, Colombatti A, De Marco L, Perris R. 2002. Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation. FASEB J 16:1903-1916.
48. McGee M, Wagner WD. 2003. Chondroitin sulfate anti-coagulant activity is linked to water transfer: Relevance to proteoglycan structure in atherosclerosis. Arterioscler Thromb Vasc Biol 23:1921-1927.
49. Merrilees MJ, Lemire JM, Fischer JW, Kinsella MG, Braun KR, Clowes AW, Wight TN. 2002. Retrovirally mediated overexpression of versican V3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ Res 90:481-487.
50. Naso MF, Zimmermann DR, Iozzo RV. 1994. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem 269:32999-33008.
51. O'Brien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, Hudkins K, Wight TN, Chait A. 1998. A comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: Co-localization of biglycan with apolipoproteins. Circulation 98:519-527.
52. Ostberg CO, Zhu P, Wight TN, Qwarnstrom EE. 1995. Fibronectin attachment is permissive for IL-1 mediated gene regulation. FEBS Lett 367:93-97.
53. Sambrook J, Fritsch EF, Maniatis T. 1998. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
54. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN, Clowes AW. 2001. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276:13372-13378.
55. Schick BP, Gradowski JF, San Antonio JD. 2001. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood 97:449-458.
56. Schick BP, Jacoby JA. 1995. Serglycin and betaglycan proteoglycans are expressed in the megakaryocyte cell line CHRF 288-11 and normal human megakaryocytes. J Cell Physiol 165:96-106.
57. Schick BP, Senkowski-Richardson S. 1992. Proteoglycan synthesis in human erythroleukaemia (HEL) cells. Biochem J 282(Pt 3):651-658.
58. Schönherr E, Järveläinen HT, Sandell LJ, Wight TN. 1991. Effects of platelet-derived growth factor and transforming growth factor-β 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 266:17640-17647.
59. Schönherr E, Järveläinen HT, Kinsella MG, Sandell LJ, Wight TN. 1993. Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb 13:1026-1036.
60. Schönherr E, Kinsella MG, Wight TN. 1997. Genistein selectively inhibits platelet-derived growth factor stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch Biochem Biophys 339:353-361.
61. Song YL, Ford JW, Gordon D, Shanley CJ. 2000. Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 20:982-988.
62. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R, Rockwell A, Yang F, Duke JL, Solomon K, George H, Bruckner R, Nagase H, Itoh Y, Ellis DM, Ross H, Wiswall BH, Murphy K, Hillman MC, Jr., Hollis GF, Arner EC, et al. 1999. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins. Science 284:1664-1666.
63. Tufvesson E, Westergren-Thorsson G. 2000. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha. J Cell Biochem 77:298-309.
64. Tyler JA. 1985. Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J 227:869-878.
65. Westergren-Thorsson G, Norman M, Bjornsson S, Endresen U, Stjernholm Y, Ekman G, Malmstrom A. 1998. Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-β in the human cervix during pregnancy and involution. Biochim Biophys Acta 1406:203-213.
66. Wight TN, Lara S, Reissen R, LeBaron R, Isner J. 1997. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am J Pathol 151:963-973.
67. Williams KJ, Tabas I. 1998. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol 9:471-474.
68. Winberg JO, Kolset SO, Berg E, Uhlin-Hansen L. 2000. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 304:669-680.
69. Xu C, Oyajobi BO, Frazer A, Kozaci LD, Russell RG, Hollander AP. 1996. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures. Endocrinology 137:3557-3565.
70. Yao LY, Moody C, Schönherr E, Wight TN, Sandell LJ. 1994. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol 14:213-225.
71. Ye L, Mora R, Akhayani N, Haudenschild CC, Liau G. 1997. Growth factor and cytokine-regulated hyaluronan-binding protein TSG-6 is localized to the injury-induced rat neointima and confers enhanced growth in vascular smooth muscle cells. Circ Res 81:289-296.
72. Zimmermann DR, Ruoslahti E. 1989. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 8: 2975-2981.